News

  • Dec 2019

    Coriell Institute for Medical Research Scientist Receives Grant to Find Drivers of Breast Cancer

    Shoghag Panjarian, PhD, a research scientist at the Coriell Institute for Medical Research, has been awarded a grant from the W. W. Smith Charitable Trust to support her search for epigenetic factors that contribute to the development and growth of breast cancer.

    read more

  • Nov 2019

    Samples from The 90+ Study Added to NIA Aging Cell Repository

    The samples – a total of 351 lymphoblastoid cell lines – are associated with a long-term study of aging known as The 90+ Study. The 90+ Study is administered by a team of scientists from the University of California Irvine and its goal is to investigate the basic lifestyle and biological factors which underlie advanced aging.

    read more

  • Nov 2019

    NINDS Awards Coriell Institute for Medical Research $7.7 Million Contract

    The five-year award will support the NINDS Human Genetics Resource Center, a collection of biological samples and corresponding demographic, clinical, and genetic data made available to qualified researchers around the world. This repository includes samples from subjects with various diseases – such as cerebrovascular disease, dystonia, epilepsy, motor neuron disease, parkinsonism, and Tourette Syndrome.

    read more

  • Nov 2019

    New Stem Cell Lines Added to Aging Cell Repository

    A pair of new induced pluripotent stem cell lines has been added to the Aging Cell Repository, a collection of biomaterials sponsored by the National Institute on Aging (NIA).

    read more

  • Sep 2019

    NIH Funds New Centers to Expand, Diversify the Human Reference Genome

    The Coriell Institute for Medical Research will support one of the two new centers tasked with generating new reference sequences of the human genome.

    read more

  • Sep 2019

    Predictors of Response to Guadecitabine Found in Relapsed/Refractory AML Patients

    Patients with acute myeloid leukemia (AML), a leukemia which arises from bone marrow tissue, often see remission following their initial treatment, but for patients whose cancer returns, there are few options. One such option is guadecitabine, a novel DNA hypomethylating drug which slows problematic changes to a person’s epigenetic profile, but the drug is ineffective in a select number of relapsed or refractory AML patients and there has not been a way to determine who stands to benefit and who does not.

    read more

  • Jul 2019

    Coriell Institute for Medical Research Now a Collaborator in Prestigious Stand Up To Cancer Grant

    The Coriell Institute for Medical Research is now participating in a prestigious SU2C Catalyst® grant from Stand Up To Cancer for the study of epigenetic therapy in treating urothelial cancer, a common form of cancer typically found in the bladder. Part of the project grant was moved to Coriell following its hiring of Jean-Pierre Issa, MD, as its new President and Chief Executive Officer.

    read more

  • Jun 2019

    New IPSC Lines Added to National Institute on Aging’s Aging Cell Repository

    Two new lines of induced pluripotent stem cells are now available to researchers through the National Institute on Aging’s Aging Cell Repository, housed and distributed by the Coriell Institute for Medical Research. The addition of these two lines brings the total number of highly-characterized iPSC lines offered through this collection to five.

    read more

  • Apr 2019

    Coriell Institute for Medical Research to Attend ACMG 2019

    The Coriell Institute for Medical Research will attend this year’s American College of Medical Genetics and Genomics’ (ACMG) Annual Clinical Genetics Meeting. This year’s event is held in Seattle, Washington from April 2 until April 6.

    read more

  • Mar 2019

    Coriell Institute for Medical Research Receives Innovation Award from Cooper’s Ferry Partnership

    The Coriell Institute for Medical Research received the inaugural Innovation Award from the Cooper’s Ferry Partnership at its annual meeting on Tuesday, March 5. This distinction recognizes Coriell’s role as a unique and critical resource to the global research community and its legacy of scientific foresight.

    read more